Topotecan

Licence status
Withdrawn: 12/09/2017
Active substances
Topotecan hydrochloride equivalent to topotecan
Dosage Form
Concentrate for solution for infusion
Licence number
PA1422/005/002
Licence holder
Fresenius Kabi Oncology Plc

Product documents

Licence information

ATC code
L01XX Other antineoplastic agents, L01XX17 topotecan
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
20/09/2013